Boehringer Ingelheim's Investigational Volasertib Receives FDA Breakthrough …

Published September 17, 2013

Boehringer Ingelheim's investigational volasertib receives FDA Breakthrough …

Filed under: drug treatment programs maryland

17, 2013 /PRNewswire/ — Boehringer Ingelheim Pharmaceuticals, Inc. today announced the FDA has granted Breakthrough Therapy designation to volasertib*, an investigational inhibitor of polo-like kinase (Plk), being evaluated for the treatment of …
Read more on PR Newswire (press release)

Binge Drinking Still a Problem in High School

Filed under: drug treatment programs maryland

"There's a big difference between binge drinkers and extreme binge drinkers," noted Jason Jerry, MD, of the Alcohol and Drug Recovery Center at Cleveland Clinic. "This may explain why there may be what appears to be conflicting data on this, as over …
Read more on MedPage Today